NextPlat to Release Third Quarter 2025 Results on Thursday, November 13, 2025
Investor Conference Call Scheduled for Thursday, November 13, 2025 at 8:30 a.m. Eastern HALLANDALE BEACH, Fla., Nov. 3, 2025 /PRNewswire/...
Investor Conference Call Scheduled for Thursday, November 13, 2025 at 8:30 a.m. Eastern HALLANDALE BEACH, Fla., Nov. 3, 2025 /PRNewswire/...
Strategic leadership additions deepen scientific rigor and quality systems of OFD Life Sciences to scale innovation in biopharma, med tech,...
LifeLoop refreshes its vision, reflecting the company's commitment to end social isolation and transform engagement in senior living communities Company...
Orchestrated by the NavaX Super Agent, the Suite includes previously launched MedDRA Coding Agent and upcoming cross-domain Agents BOSTON, Nov. 3,...
Next-generation platform will unite modern, purpose-built workflows with the industry's mostconnected care network to transform senior living operations TORONTO, Nov....
RELiZORB is now available for patients of all ages to hydrolyze fats during enteral feeding WALTHAM, Mass., Nov. 3, 2025...
New coalition of innovators – including Lumeris, Teladoc Health, Nuna, Deloitte, and Unite Us– mobilizes to bring connected, sustainable care...
LOS ANGELES, Nov. 3, 2025 /PRNewswire/ -- Partillion Bioscience today announced the launch of Developer Kits, a ready foundation for...
WESTPORT, Conn., Nov. 3, 2025 /PRNewswire/ -- LogicSource, the leading provider of procurement services and technology, is pleased to announce...
MIAMI, Nov. 3, 2025 /PRNewswire/ -- Sitero, a technology-enabled Clinical Research Organization (CRO), today announced it has acquired the AI...
LAGUNA HILLS, Calif., Nov. 3, 2025 /PRNewswire/ -- e123, the leading health insurance distribution management platform, announces the launch of...
Independent Wireless Carrier Steps in to Keep Americans Connected for as Long as Federal Food Assistance Remains Suspended IRVINE, Calif.,...
LOS ALTOS HILLS, CA / ACCESS Newswire / November 3, 2025 / Reprieve House has opened its doors as Silicon...
Bringing Next-Generation Wellness to a Global Audience with Multilingual, Accessible AI Solutions MESA, ARIZONA / ACCESS Newswire / November 3,...
- CID-103 is a potential best-in-class, anti-CD38 monoclonal antibody- Phase 1 dose escalation study in Immune Thrombocytopenia (ITP) results and...
Dr. Naderi reveals how younger generations are embracing prejuvenation with collagen-boosting treatments and skincare to maintain a natural, youthful glow...
Demonstrated feasibility of effective DNA delivery with Company's xPhore™ nanoparticle technologyDNA delivery technology to be offered as GenePhore™ to biotech...
Key Highlights:Pivot Controller Line Validated: Manufacturing line has now been validated for human-use production in support of expected Q1 2026...
SHELTON, CONNECTICUT / ACCESS Newswire / November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
LOS GATOS, CA / ACCESS Newswire / November 3, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a...